AVENTIS PHARMA S has a total of 47 patent applications. Its first patent ever was published in 1998. It filed its patents most often in New Zealand and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DAIICHI ASUBIO PHARMA CO LTD, TAKEDA FARMAS JUTIKAL KOMPANI LTD and ATHERSYS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | New Zealand | 46 | |
#2 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Fermentation | |
#7 | Measuring microorganism processes | |
#8 | Sugars | |
#9 | Polysaccharides | |
#10 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Bissery Marie-Christine | 5 |
#2 | Carry Jean-Christophe | 4 |
#3 | Mignani Serge | 4 |
#4 | Viskov Christian | 3 |
#5 | Wahl Florence | 3 |
#6 | Filoche Bruno | 3 |
#7 | Perrin Elisabeth | 3 |
#8 | Stutzmann Jean-Marie | 3 |
#9 | Bashiardes Georges | 2 |
#10 | Rocher Corinne | 2 |
Publication | Filing date | Title |
---|---|---|
NZ537411A | Heparin-derived polysaccharide mixtures and preparation method | |
US2005202528A1 | Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof | |
NZ527655A | Combination of a taxane (docetaxel) and a cyclin-dependent kinase inhibitor (flavopiridol) | |
NZ520802A | Compositions useful for regulating parkin gene activity | |
NZ512986A | Polypeptides derived from JNK3 | |
NZ517119A | Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma |